ARDEN HILLS, Minn.--()--IntriCon Corporation (NASDAQ: IIN), a designer, developer, manufacturer and distributor of miniature and micro-miniature body-worn devices, today announced it will introduce Audion6™, its new six-channel hearing aid amplifier, and the Lumen™ 1000 wireless hearing system at the 57th annual International Congress of Hearing Aid Acousticians (EUHA) in Munich, Germany October 24-26, 2012.
“We’re excited to unveil our latest technology advancements at this year’s EUHA event, Europe’s most prestigious hearing health conference”
“We’re excited to unveil our latest technology advancements at this year’s EUHA event, Europe’s most prestigious hearing health conference,” said Mark S. Gorder, president and chief executive officer of IntriCon. “Audion6 broadens our amplifier product offering—giving customers more options to be competitive in today’s increasingly complex and technical hearing health market.”
IntriCon’s Audion6 is a feature-rich amplifier designed to fit a wide array of applications. In addition to multiple compression channels, the amplifier has a complete set of proven adaptive features which greatly improve the user experience.
Along with Audion6, IntriCon will preview its Lumen 1000 wireless hearing system, a next-generation product within the company’s existing Lumen family of products.
Said Gorder, “The Lumen system incorporates our intuitive Physiolink™ wireless technology to allow clear communication. The flexStrem™, voiceStream™ and tvStream™ accessories allow audio or music, television audio or a companion’s voice to be wirelessly broadcasted directly to the hearing aid—making the system significantly more versatile than traditional hearing devices.”
In addition to Audion6 and Lumen 1000, IntriCon also will feature its advanced Lumen™ 200+ and APT™ D Open ITC hearing aids at EUHA.
Visit IntriCon at booth Fantasie 1, Level C, 9:30 a.m.-17:00 p.m., local time, Wednesday, Oct. 24, Thursday, Oct. 25, and Friday, Oct. 26.
About IntriCon Corporation
Headquartered in Arden Hills, Minn., IntriCon Corporation designs, develops and manufactures miniature and micro-miniature body-worn devices. These advanced products help medical, healthcare and professional communications companies meet the rising demand for smaller, more intelligent and better connected devices. IntriCon has facilities in the United States, Asia and Europe. The company’s common stock trades under the symbol “IIN” on the NASDAQ Global Market. For more information about IntriCon, visit www.intricon.com.
Statements made in this release and in IntriCon’s other public filings and releases that are not historical facts or that include forward-looking terminology are “forward-looking statements” within the meaning of the Securities Exchange Act of 1934, as amended. These forward-looking statements may be affected by known and unknown risks, uncertainties and other factors that are beyond IntriCon’s control, and may cause IntriCon’s actual results, performance or achievements to differ materially from the results, performance and achievements expressed or implied in the forward-looking statements. These risks, uncertainties and other factors are detailed from time to time in the company’s filings with the Securities and Exchange Commission, including the Annual Report on Form 10-K for the year ended December 31, 2011. The company disclaims any intent or obligation to publicly update or revise any forward-looking statements, regardless of whether new information becomes available, future developments occur or otherwise.